Richard Sullivan reflects on major issues cancer care faces in radiotherapy
Richard Sullivan, Director of the Institute of Cancer Policy, shared a post on LinkedIn:
“Radiotherapy is one of the core modalities for cure and palliation in cancer care with a proven return on investment. But a new study led by Fabio Moraes at Queen’s University and colleagues found that to meet global radiotherapy demands up to 2045 between 16,000 and 20,000 new LINACs will be needed.
Authors: Fabio Moraes et al.
Whilst the investment per country for upper middle and above will be within reach of domestic budgets, for most countries below this group, especially those with significant debt and liquidity issues, the capital and recurrent costs will be unaffordable.
The 2015 Lancet Oncology Commission on Radiotherapy estimated that scale up radiotherapy costs just to 2035 would require up to US$14·1 billion for low-income countries, and US$33·3 billion for lower middle-income countries. And this is a conservative estimate. It does not consider advances in technology, nor the expansion in workforce that will be required, irrespective of whether more radiotherapy planning can be augmented using artificial intelligence.
The radiotherapy community has some of the best comparative intelligence on the scale of the global challenges, but sustainable economic solutions (domestic and external) continue to allude. Part of the problem, and this is a truism not just for radiotherapy, is that the focus is technological innovation rather than national implementation and scale-up.
Authors: D. Rodin et al.
We know from previous King’s-Queens studies of Brazil that national radiotherapy plans become severely delayed, have huge cost overruns and capacity is maldistributed.
Authors: Andre Gouveia et al.
Add to this the considerable barriers to building a capable workforce and the inevitable conclusion is that a lot more effort needs to go towards implementation and operational science to support domestic and donor planning.”
Authors: Thea Hope-Johnson et al.
More posts featuring Richard Sullivan.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023